The Journal of Clinical Psychiatry stands as a beacon of excellence in the realm of psychiatric literature. Our expert editors are dedicated to bringing forth groundbreaking research, insightful reviews, and thought-provoking commentaries. We strive to further the field of psychiatry by disseminating knowledge that is evidence-based, clinically relevant, and impactful. Our commitment to excellence ensures that psychiatrists have access to the latest advancements, best practices, and emerging trends in the world of mental health.
Recently published articles about Journal
Consensus Statement
Developing a Treatment-Resistant Depression Consultation Program, Part II: Assessment
May 7, 2025
Consensus recommendations about the goals of a consultation for treatment-resistant depression include establishing the primary diagnosis and comorbidities, clarifying symptoms, identifying goals, documenting treatment history, identifying treatment barriers, and...
Recent JCP Articles on Journal
Original Research
Preference for Lisdexamfetamine vs CBT for Binge-Eating Disorder
May 7, 2025
CBT and pharmacotherapy with lisdexamfetamine resulted in significant improvements in binge-eating disorder. Participants’ preferences for treatments were not associated with sociodemographic or clinical characteristics and did not moderate treatment...
Commentary
Lower Risk of Cardiovascular Disorders in Antidepressant-Treated Women Veterans: Encouraging Findings but Concerns Remain
May 7, 2025
Comments on a study by Sumner et al that followed 609,546 women veterans for a mean of 8.8 years to look at associations of antidepressants with incident CVD.
Recent PCC Articles on Journal
Case Report
Risperidone Long-Acting Injection Reduced Emergency Visits in a Patient With Comorbid Autism Spectrum and Borderline Personality Disorders
May 1, 2025
This case demonstrates that LAI risperidone may support emotional and interpersonal improvements in a patient with both borderline personality disorder and autism spectrum disorder.